- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Stenocare A/S: Interim report third quarter 2025 | 52 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 30.09.2025. The report, which has not been... ► Artikel lesen | |
| 27.08. | Trading in STENOCARE shares by closely related party to board member | 1 | Cision News | ||
| 21.08. | Stenocare A/S: Interim report second quarter 2025 | 163 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 30.06.2025. The report, which has not been... ► Artikel lesen | |
| 15.05. | Communiqué from the Annual General Meeting of STENOCARE | 2 | Cision News | ||
| 08.05. | Stenocare A/S: Interim report first quarter 2025 | 151 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 31.03.2025. The report, which has not been... ► Artikel lesen | |
| STENOCARE Aktie jetzt für 0€ handeln | |||||
| 02.05. | Stenocare A/S: Medical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE | 197 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("Stenocare") is pleased to announce that the Danish Parliament has officially passed legislation to make Denmark's... ► Artikel lesen | |
| 03.04. | ASTRUM 10-10 Ext Stenocare - verbesserte Bioverfügbarkeit mit neuem medizinischem Cannabisextrakt | 371 | news aktuell | Koblenz (ots) - Die ADREXpharma GmbH stellt einen neuen und verbesserten medizinischen Cannabisextrakt für die Behandlung von Patienten vor. Das neue Produkt heißt "ASTRUM 10-10 Ext Stenocare" und enthält... ► Artikel lesen | |
| 27.02. | Stenocare A/S: Q4 and Annual Financial Statement Release 2024 | 263 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2024 - 31.12.2024. The report, which has not been... ► Artikel lesen | |
| 27.01. | First North Denmark: Stenocare A/S - admission to trading of new shares | 234 | GlobeNewswire | New shares in Stenocare A/S will be admitted to trading on Nasdaq First North Growth Market Denmark as per 28 January 2025 due to completion of a rights issue.
ISIN:
DK0061078425
Name:
Stenocare
Number... ► Artikel lesen | |
| 02.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 02.01.2025 | 618 | Xetra Newsboard | Das Instrument S7C DK0061078425 STENOCARE DK-,08 EQUITY wird cum Kapitalmassnahme gehandelt am 02.01.2025 und ex Kapitalmassnahme am 03.01.2025 The instrument S7C DK0061078425 STENOCARE DK-,08 EQUITY... ► Artikel lesen | |
| 17.12.24 | Stenocare A/S: STENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil | 159 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
Stenocare has received approval from the Danish Medicines Agency to start selling a new medical cannabis oil product to Danish... ► Artikel lesen | |
| 05.11.24 | Stenocare A/S: Interim Report Third Quarter 2024 | 225 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2024 - 30.09.2024. The report, which has not been reviewed... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,355 | +0,11 % | Aurora Cannabis Inc (3): Aurora Cannabis to issue Q2 fiscal 2026 results Nov. 5 | ||
| ABBVIE | 197,20 | 0,00 % | AbbVie erzielt positive Studienergebnisse mit RINVOQ bei rheumatoider Arthritis | Der US-Pharmakonzern AbbVie hat in einer späten klinischen Studie positive Ergebnisse für seinen Wirkstoff Upadacitinib (Handelsname RINVOQ) erzielt. In der Phase-3b/4-Studie SELECT-SWITCH wurde das... ► Artikel lesen | |
| CANOPY GROWTH | 1,142 | 0,00 % | Cannabis-Aktien mit Trump-Schub: Bioxyne, Aurora und Canopy Growth im Fokus | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 1,271 | +1,36 % | Tilray Brands, Inc.: Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work | ||
| INNOCAN PHARMA | 10,200 | +4,08 % | InnoCan Pharma: Jetzt die große Pre-Nasdaq-IPO Rallye? | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| DERMAPHARM | 32,750 | -0,76 % | Kurs der Dermapharm-Aktie verharrt auf Vortags-Niveau (31,85 €) | Der Kurs der der Dermapharm-Aktie kommt kaum von der Stelle. Der jüngste Kurs betrug 31,85 Euro. Ein geringes Minus von 0,78 Prozent zeigt die Kurstafel für der Anteilsschein von Dermapharm an. Die... ► Artikel lesen | |
| CRONOS GROUP | 2,092 | +0,58 % | Stocks in Play: Cronos Group Inc. | ||
| SYNBIOTIC | 2,585 | -2,64 % | Temporary headwinds from regulatory uncertainty; chg. est.: SYNBIOTIC faces short-term challenges due ... | To recap: SYNBIOTIC is a European holding company active in the medical cannabis and industrial hemp markets with twelve holdings. Following the recent organizational restructuring, the group is now... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,470 | 0,00 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 6,665 | +6,73 % | Top U.S. Marijuana Stocks to Watch in October 2025: Trulieve, Curaleaf, and Green Thumb Dominate the Industry | ||
| SNDL | 1,906 | +0,79 % | SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting Results | EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders... ► Artikel lesen | |
| CRESCO LABS | 1,090 | +13,01 % | Cresco Labs to Report Third Quarter 2025 Financial Results on November 5, 2025 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,173 | +18,23 % | XFRA 0NF0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMYDECINE INNOVAT.GRP... ► Artikel lesen |
Das Unternehmen STENOCARE A/S kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,30 % bei einem Aktienkurs von 0,169 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STENOCARE A/S finden Sie auf Wallstreet Online.